Etentamig

(Synonyms: ABBV-383; TNB 383B)
Revisión del cliente

Based on 1 Customer Validation

Etentamig (ABBV-383; TNB 383B) is a T cell engager targeting BCMA and CD3. Etentamig redirects T cell-mediated cytotoxicity by binding BCMA (Kd ≈ 0.7 nM) and activating the T cell co-receptor CD3 (Kd = 1.3 μM), mediates BCMA-specific plasma cell killing and target cell lysis, and has low-activation properties that decouple T cell activation from cytokine release. Etentamig exhibits anti-myeloma efficacy and can be used for research on relapsed/refractory multiple myeloma.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza : 99%
  • No. CAS: 2490552-52-6
  • Peso molecular:123.8 kDa
  • Almacenamiento:
    Shipping with dry ice

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Actividad biológica
  • Chemical Information
  • Protocolo
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00